(Q42663428)

4 November 2017

PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle (English)

1 reference

4 November 2017

1

1 reference

4 November 2017

Marcello Coletta

2

1 reference

4 November 2017

Fabrizio De Grandis

series ordinal

3

1 reference

4 November 2017

Stefano M Cannata

series ordinal

4

1 reference

4 November 2017

Giulio Cossu

series ordinal

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

27 July 2008

1 reference

4 November 2017

1 reference

4 November 2017

14

1 reference

4 November 2017

973-978

1 reference

4 November 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.1852

4 November 2017

0 references

cites work

Pathogenesis of muscular dystrophies

1 reference

New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials.

21 January 2018

1 reference

7 January 2021

128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands

1 reference

7 January 2021

Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

1 reference

7 January 2021

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

1 reference

7 January 2021

Accumulation of collagen and altered fiber-type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic mouse

1 reference

7 January 2021

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

1 reference

7 January 2021

1 reference

7 January 2021

mdx mice show progressive weakness and muscle deterioration with age

1 reference

7 January 2021

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

1 reference

7 January 2021

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

1 reference

7 January 2021

Structure and function of placental growth factor

1 reference

7 January 2021

Lower limb surgery in Duchenne muscular dystrophy

1 reference

7 January 2021

In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents

1 reference

7 January 2021

Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy.

1 reference

7 January 2021

Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche.

1 reference

7 January 2021

A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers

1 reference

7 January 2021

A population of myogenic cells derived from the mouse neural tube.

1 reference

7 January 2021

Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis

1 reference

7 January 2021

Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability

1 reference

7 January 2021

Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion

1 reference

7 January 2021

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy

1 reference

7 January 2021

The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM.1852

1 reference

4 November 2017

1 reference